浙江三星新材股份有限公司 募集资金管理制度 浙江三星新材股份有限公司 募集资金管理制度 第一章 总则 第一条 为规范浙江三星新材股份有限公司（以下简称"公司"）募集资金的 管理和使用，保护投资者的权益，根据《中华人民共和国公司法》《中华人民共 和国证券法》《上市公司证券发行管理办法》《上市公司募集资金监管规则》《上 海证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引第 1 号— —规范运作》等有关法律、法规、规范性文件及《浙江三星新材股份有限公司章 程》（以下简称"《公司章程》"），特制定本制度。 第二条 本制度所称募集资金是指公司通过发行股票及其衍生品种，向投资 者募集并用于特定用途的资金，但不包括公司为实施股权激励计划募集的资金监 管。 本制度所称超募资金是指实际募集资金净额超过计划募集资金金额的部分。 第三条 公司董事会应建立募集资金存储、使用和管理的内部控制制度，对 募集资金存储、使用、变更、监督和责任追究以及募集资金使用的申请、分级审 批权限、决策程序、风险控制措施及信息披露程序等内容进行明确规定。 公司应当将募集资金存储、使用和管理的内部控制制度及时在上海证券交易 所（以下简称"上交所 ...

证券代码：603578 证券简称：三星新材 公告编号：2025-043 浙江三星新材股份有限公司 关于取消公司监事会并修订《公司章程》及部分治理制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江三星新材股份有限公司（以下简称"公司"）于 2025 年 7 月 28 日召开 了公司第五届董事会第九次会议，审议通过了《关于取消公司监事会并修订<公 司章程>的议案》和《关于修订公司部分治理制度的议案》，现将相关情况公告如 下： 一、关于取消监事会的情况 为全面贯彻落实最新法律法规要求，确保公司治理与监管规定保持同步，进 一步规范公司运作机制，提升公司治理水平，根据 2024 年 7 月 1 日起实施的新 《公司法》以及《上市公司章程指引（2025 年 3 月修订）》《上市公司股东会规 则（2025 年 3 月修订）》《上海证券交易所股票上市规则（2025 年 4 月修订）》等 相关法律法规、规范性文件的规定，结合公司实际情况，公司拟取消公司监事会， 同时免去李发现先生、刘坤明先生所担任的公司第五届监事会非职工代表监事职 ...

证券代码：603578 证券简称：三星新材 公告编号：2025-044 浙江三星新材股份有限公司 关于召开2025年第四次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东大会召开日期：2025年8月13日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票系 统 一、召开会议的基本情况 (一)股东大会类型和届次 2025年第四次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 8 月 13 日 14 点 00 分 召开地点：浙江湖州市德清县禹越镇杭海路 333 号公司办公楼三楼会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 8 月 13 日 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票，应按照《上海证券交易所上市公司自律监管 ...

浙江三星新材股份有限公司（以下简称"公司"或"三星新材"）第五届董 事会第九次会议于 2025 年 7 月 22 日以通讯方式发出会议通知，会议于 2025 年 7 月 28 日上午在公司办公楼三楼会议室以现场结合通讯方式召开。 会议应出席董事 8 人，实际亲自出席董事 6 人，非独立董事杨敏先生因公出 差未能亲自出席会议，其授权委托非独立董事张以涛先生代为出席并代为行使表 决权；非独立董事黄运通先生因个人原因请假，未出席会议，也未委托其他董事 代为出席和代为行使表决权。本次会议由公司董事长仝小飞先生主持，公司部分 监事和高级管理人员列席了会议。 证券代码：603578 证券简称：三星新材 公告编号：2025-042 浙江三星新材股份有限公司 第五届董事会第九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 本次会议的召集、召开及表决程序符合有关法律、行政法规、部门规章、规 范性文件及《三星新材公司章程》的规定，表决形成的决议合法、有效。 二、董事会会议审议情况 （一）审议通过《关于取消公 ...

[Zhejiang Sanxing New Material Co., Ltd. 2025 H1 Earnings Forecast](index=1&type=section&id=Zhejiang%20Sanxing%20New%20Material%20Co.%2C%20Ltd.%202025%20H1%20Earnings%20Forecast) [Core Data of the Current Earnings Forecast](index=1&type=section&id=I.%20Current%20Period%20Earnings%20Forecast) The company anticipates a net loss for H1 2025, with preliminary, unaudited estimates provided 2025 H1 Earnings Forecast | Metric | Forecasted Amount (RMB) | | :--- | :--- | | Net Profit Attributable to Parent Company Shareholders | -44.0 million to -23.0 million | | Net Profit Attributable to Parent Company Shareholders after Deducting Non-recurring Gains and Losses | -45.8 million to -24.8 million | - The forecast period covers January 1, 2025, to June 30, 2025[4](index=4&type=chunk) - The company emphasizes that the forecasted figures are **preliminary and have not been audited** by a certified public accountant[8](index=8&type=chunk) [Prior-Year Period Performance Review](index=2&type=section&id=II.%20Operating%20Performance%20and%20Financial%20Condition%20in%20the%20Same%20Period%20of%20the%20Previous%20Year) In contrast to the 2025 forecast, the company was profitable in the same period of 2024 2024 H1 (Prior-Year Period) Performance Data | Metric | Amount (RMB) | | :--- | :--- | | Total Profit | 57.34 million | | Net Profit Attributable to Parent Company Shareholders | 56.49 million | | Net Profit Attributable to Parent Company Shareholders after Deducting Non-recurring Gains and Losses | 55.75 million | | Earnings Per Share | 0.31 | [Analysis of Reasons for Forecasted Loss](index=2&type=section&id=III.%20Main%20Reasons%20for%20the%20Forecasted%20Loss%20in%20the%20Current%20Period) The projected loss is attributed to photovoltaic industry imbalances and planned asset impairment provisions - The primary cause is a **supply-demand imbalance in the photovoltaic industry**, leading to low prices and increased competition, which resulted in losses for the company's photovoltaic glass business and impacted overall performance[11](index=11&type=chunk) - The company plans to **provide for impairment on certain assets** showing signs of decline in accordance with accounting principles, which negatively impacts expected profits[11](index=11&type=chunk) - To address these challenges, the company will enhance risk control, market forecasting, and implement refined production management and cost-reduction measures to improve competitiveness[11](index=11&type=chunk) [Risk Warnings and Other Disclosures](index=2&type=section&id=IV.%20Risk%20Warnings%20and%20V.%20Other%20Explanatory%20Matters) The company confirms no major uncertainties affecting this forecast but notes the data is preliminary and unaudited - The company states that there are currently **no significant uncertainties** that could affect the accuracy of this earnings forecast[12](index=12&type=chunk) - Investors are advised that the forecast data is preliminary and unaudited; final accurate financial data will be disclosed in the company's official 2025 semi-annual report[13](index=13&type=chunk)[14](index=14&type=chunk)

Summary of Key Points Core Viewpoint - The announcement details the pledge of shares by a major shareholder, Yang Min, who holds 23.32% of the company's total shares, indicating a significant financial maneuver that may impact the company's stock performance and investor sentiment [1][2]. Group 1: Shareholder Pledge Details - Yang Min has pledged 42,054,012 shares, which is 7.20% of the total shares held by him and his associate, Yang Ayong, and 3.06% of the company's total shares [1]. - After the pledge, the total shares pledged by Yang Min and Yang Ayong amount to 31,557,000 shares, representing 41.21% of their combined holdings and 17.50% of the company's total shares [1]. - The pledge is for personal financial needs and does not involve any major asset restructuring or performance compensation guarantees [1]. Group 2: Cumulative Pledge Situation - Prior to this pledge, Yang Min and Yang Ayong had a cumulative pledge of 42,054,012 shares, which accounted for 23.32% of the company's total shares [1]. - After the new pledge, the cumulative pledged shares for Yang Min and Yang Ayong are 76,576,500 shares, which is 42.46% of their total holdings [1]. - The announcement emphasizes that the company will continue to monitor the situation regarding shareholder pledges and fulfill its information disclosure obligations as required [2].

证券代码：603578 证券简称：三星新材 公告编号：2025-040 浙江三星新材股份有限公司 关于持股 5%以上股东部分股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 浙江三星新材股份有限公司（以下简称"公司"）持股 5%以上的股东杨敏 先生持有公司股份 42,054,012 股，占公司总股本的 23.32%。本次杨敏先生质押 551 万股，占其所持公司股份的 13.10%。本次质押后，杨敏先生累计质押股份 2351 万股，占其所持公司股份的 55.90%，占公司总股本的 13.04%。 杨敏先生及其一致行动人杨阿永先生合计持有公司股份 76,576,500 股， 占公司总股本的 42.46%。本次质押股份占两人合计所持公司股份的 7.20%，占公 司总股本的 3.06%。本次质押后，杨敏先生及其一致行动人杨阿永先生合计质押 股份 3155.7 万股，占两人合计持有公司股份的 41.21%，占公司总股本的 17.50%。 公司于 2025 年 6 月 26 日收到公司持股 5%以上的股东杨敏 ...

Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江三星新材股份有限公司（以下简称"公司"）于 2025 年 6 月 23 日召开 了第五届董事会第八次会议，审议通过了《关于聘任公司财务负责人的议案》。 根据相关法律法规及《公司章程》的相关规定，经公司总经理提名，并经公 司第五届董事会提名委员会第二次会议、审计委员会第八次会议资格审查通过， 公司董事会同意聘任陈正君先生（简历见附件）为公司财务负责人，任期自本次 董事会审议通过之日起至第五届董事会届满之日止。 陈正君先生的任职资格符合《公司法》《上海证券交易所股票上市规则》等 相关法律法规及《公司章程》的相关规定。截至本公告披露日，陈正君先生未持 有公司股票，与公司的董事、高级管理人员、实际控制人及持股 5%以上的股东 不存在关联关系，不存在《上海证券交易所上市公司自律监管指引第 1 号—规范 运作》所列不适合担任公司高级管理人员的情形。 证券代码：603578 证券简称：三星新材 公告编号：2025-039 浙江三星新材股份有限公司 特此公告。 浙江三星新材股份有限公司董事会 ...

关于聘任公司财务负责人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江三星新材股份有限公司（以下简称"公司"）于 2025 年 6 月 23 日召开 了第五届董事会第八次会议，审议通过了《关于聘任公司财务负责人的议案》。 根据相关法律法规及《公司章程》的相关规定，经公司总经理提名，并经公 司第五届董事会提名委员会第二次会议、审计委员会第八次会议资格审查通过， 公司董事会同意聘任陈正君先生（简历见附件）为公司财务负责人，任期自本次 董事会审议通过之日起至第五届董事会届满之日止。 证券代码：603578 证券简称：三星新材 公告编号：2025-039 浙江三星新材股份有限公司 陈正君先生的任职资格符合《公司法》《上海证券交易所股票上市规则》等 相关法律法规及《公司章程》的相关规定。截至本公告披露日，陈正君先生未持 有公司股票，与公司的董事、高级管理人员、实际控制人及持股 5%以上的股东 不存在关联关系，不存在《上海证券交易所上市公司自律监管指引第 1 号—规范 运作》所列不适合担任公司高级管理人员的情形。 特此公告。 ...